Safety and efficacy of ablative fractional CO2 laser thrapy for external genital and the vagina in women with breast cancer
Not Applicable
- Conditions
- Symptom of vulvovaginal atrophy caused from low estrogen state
- Registration Number
- JPRN-UMIN000027742
- Lead Sponsor
- Medical corporation LEADING GIRLS
- Brief Summary
Vaginal discomfort improved in all treated patients. The improvement in urinary tract symptoms was not significant, but in some patients there was a dramatic improvement. No serious side effects were observed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 7
Inclusion Criteria
Not provided
Exclusion Criteria
1) heart disease 2) severely lung disease 3) pelvic organ prolapse (more than 3) 4) pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of AFLT on breast cancer patients at pre, 3 months, 6 months and one year by questionnaire
- Secondary Outcome Measures
Name Time Method Effect of AFLT on breast cancer patients at pre, 3 months, 6 months and one year by objective evaluation and questionnaire.